Schneider, Yves-Jacques

Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach

des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 1,305

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Boelaert, J. R., de Locht, M., Van Cutsem, J., Kerrels, V, Cantinieaux, B., Verdonck, A., Van Landuyt, H. W., & Schneider, Y. J. (1993) · Journal of Clinical Investigation

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 340

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 331

Selenium bioaccessibility and bioavailability in Se-enriched food supplements

Thiry, C., Schneider, Y.-J., Pussemier, L., De Temmerman, L., & Ruttens, A. (2013) · Biological Trace Element Research

Selenium in Biological SystemsOrganoselenium and organotellurium chemistry

Cited by 67

Reducing agent can be omitted in the incubation medium of the batch in vitro fermentation model of the pig intestines

Poelaert, C., Nollevaux, G., Boudry, C., Taminiau, B., Nezer, C., Daube, G., Schneider, Y.-J., Portetelle, D., Théwis, A., & Bindelle, J. (2018) · animal

Animal Nutrition and PhysiologyGut microbiota and health

Cited by 6